Evidence map›Paper›PMID 40576334›Full record

ArticleThe ISME journal2025

Syntrophic bacterial and host-microbe interactions in bacterial vaginosis.

Elliot M Lee, Sujatha Srinivasan, Samuel O Purvine, Tina L Fiedler, Owen P Leiser, Sean C Proll, Samuel S Minot, Danijel Djukovic, Daniel Raftery, Christine Johnston and 2 more

Abstract read
In one paragraph

Article in The ISME journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elliot M LeeVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N Seattle, WA 98109, United States.
Sujatha SrinivasanVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N Seattle, WA 98109, United States.
Samuel O PurvineEnvironmental Molecular Sciences Division, Pacific Northwest National Laboratory, 3335 Innovation Blvd, Richland, WA 99354, United States.
Tina L FiedlerVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N Seattle, WA 98109, United States.
Owen P LeiserChemical and Biological Signatures, Pacific Northwest National Laboratory, 1100 Dexter Avenue N, Seattle, WA 98109, United States.
Sean C ProllVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N Seattle, WA 98109, United States.
Samuel S MinotVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N Seattle, WA 98109, United States.
Danijel DjukovicDepartment of Anesthesiology and Pain Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, United States.
Daniel RafteryDepartment of Anesthesiology and Pain Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, United States.
Christine JohnstonVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N Seattle, WA 98109, United States.
David N FredricksVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N Seattle, WA 98109, United States.
Brooke L Deatherage KaiserChemical and Biological Signatures, Pacific Northwest National Laboratory, 1100 Dexter Avenue N, Seattle, WA 98109, United States.

Funding

Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
Urethral microbiome and non-gonococcal urethritis in men who have sex with men (MU19AI113173 · NIAID · UNIVERSITY OF WASHINGTON · PI MARRAZZO, JEANNE M · 2014 to 2018
$14.3M
The Role of Uncultivated Bacteria in Bacterial VaginosisR01AI061628 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FREDRICKS, DAVID NEAL · 2006 to 2016
$6.6M
Multiplexed UPLC-MS/MS System for Advanced Target MetabolomicsS10OD021562 · OD · UNIVERSITY OF WASHINGTON · PI RAFTERY, DANIEL · 2016 to 2016
$596k
NIAID NIH HHS R01 AI061628NIAID NIH HHS U19 AI113173NIGMS NIH HHS GM103493NIGMS NIH HHS P41 GM103493NIH HHS R01AI061628NIH HHS S10 OD021562NIH HHS U19 AI113173ORIP NIH HHS S10OD021562
6 · The paper itself

Abstract

Bacterial vaginosis (BV) is a common, polymicrobial condition of the vaginal microbiota that is associated with symptoms such as malodor and excessive discharge, along with increased risk of various adverse sequelae. Host-bacteria and bacteria-bacteria interactions are thought to contribute to the condition, but many of these functions have yet to be elucidated. Using untargeted metaproteomics, we identified 1068 host and 1418 bacterial proteins in a set of cervicovaginal lavage samples collected from 20 participants with BV and 9 who were negative for the condition. We identified Dialister micraerophilus as a major producer of malodorous polyamines and identified a syntrophic interaction between this organism and Fannyhessea vaginae that leads to increased production of putrescine, a metabolite characteristic of BV. Although formate synthesis has not previously been noted in BV, we discovered diverse bacteria associated with the condition express pyruvate formate-lyase enzymes in vivo and confirm these organisms secrete formic acid in vitro. Sodium hypophosphite efficiently inhibited this function in multiple taxa. We also found that the fastidious organism Coriobacteriales bacterium DNF00809 can metabolize formic acid secreted by Gardnerella vaginalis, representing another syntrophic interaction. We noted an increased abundance of the host epithelial repair protein transglutaminase 3 in the metaproteomic data, which we confirmed by enzyme-linked immunosorbent assay. Other proteins identified in our samples implicate Finegoldia magna and Parvimonas micra in the production of malodorous trimethylamine. Some bacterial proteins identified represent novel targets for future therapeutics to disrupt BV communities and promote vaginal colonization by commensal lactobacilli.

Indexed as

BacteriaHost Microbial InteractionsVaginosis, BacterialAdultBacterial ProteinsFemaleFormatesHumansMicrobiotaProteomicsPutrescineVaginaBacterial ProteinsFormatesformic acidPutrescinebacterial vaginosisdrug targetsfermentationhost–microbe interactionsmetabolismmetaproteomicsmicrobial ecologymicrobiomesyntrophy

Identifiers

PMID40576334
PMCPMC12208373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.